About our applications
UMAB offers end-to-end monoclonal antibody development, from target design to high-affinity, functionally validated antibodies.
Using a unique immunization and screening workflow, we support academic research with reliable and scalable antibody solutions.
Our applications
- Unique immunization method to generate high affinity antibodies to surface molecules (KD 10-10 to 10-11 )
- 5000-10000 generated hybridomas screened for binding
- Screening on FACS, selection of top 5-10 antibodies
- From target sequence to mouse hybridoma’s in 6-9 months
- Sequencing of hybridomas
- Chimerization on 5-10 mAbs within 3-4 months
- Produce antibodies of patented sequences for academic use
